IL-17 expressed by either CD4+ or CD8+ T cells possibly plays a key role in MIS-C pathogenesis, as children with acute MIS-C had higher IL-17 values compared to convalescent COVID-19 or MIS-C patients. This evidence concerns the gene IL17A and COVID-19.